SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-063622
Filing Date
2021-03-01
Accepted
2021-03-01 16:41:03
Documents
14
Period of Report
2021-02-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d14241d8k.htm   iXBRL 8-K 34013
2 EX-99.1 d14241dex991.htm EX-99.1 10220
6 GRAPHIC g14241g0227112210241.jpg GRAPHIC 3726
  Complete submission text file 0001193125-21-063622.txt   175450

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20210223.xsd EX-101.SCH 3081
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20210223_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20210223_pre.xml EX-101.PRE 10960
7 EXTRACTED XBRL INSTANCE DOCUMENT d14241d8k_htm.xml XML 3231
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 21698575
SIC: 2834 Pharmaceutical Preparations